Your browser doesn't support javascript.
loading
TP53 germline mutation testing in early-onset breast cancer: findings from a nationwide cohort.
Bakhuizen, J J; Hogervorst, F B; Velthuizen, M E; Ruijs, M W; van Engelen, K; van Os, T A; Gille, J J; Collée, M; van den Ouweland, A M; van Asperen, C J; Kets, C M; Mensenkamp, A R; Leter, E M; Blok, M J; de Jong, M M; Ausems, M G.
Afiliación
  • Bakhuizen JJ; Department of Genetics, University Medical Center Utrecht, PO Box 85090, 3508 AB, Utrecht, The Netherlands. j.j.bakhuizen-2@umcutrecht.nl.
  • Hogervorst FB; Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Velthuizen ME; Department of Genetics, University Medical Center Utrecht, PO Box 85090, 3508 AB, Utrecht, The Netherlands.
  • Ruijs MW; Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • van Engelen K; Department of Clinical Genetics, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
  • van Os TA; Department of Clinical Genetics, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
  • Gille JJ; Department of Clinical Genetics, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
  • Collée M; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • van den Ouweland AM; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • van Asperen CJ; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.
  • Kets CM; Department of Human Genetics, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.
  • Mensenkamp AR; Department of Human Genetics, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.
  • Leter EM; Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Blok MJ; Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands.
  • de Jong MM; Department of Clinical Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Ausems MG; Department of Genetics, University Medical Center Utrecht, PO Box 85090, 3508 AB, Utrecht, The Netherlands.
Fam Cancer ; 18(2): 273-280, 2019 04.
Article en En | MEDLINE | ID: mdl-30607672
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Pruebas Genéticas / Proteína p53 Supresora de Tumor / Síndrome de Li-Fraumeni / Asesoramiento Genético Tipo de estudio: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies Límite: Adolescent / Adult / Female / Humans País/Región como asunto: Europa Idioma: En Revista: Fam Cancer Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Pruebas Genéticas / Proteína p53 Supresora de Tumor / Síndrome de Li-Fraumeni / Asesoramiento Genético Tipo de estudio: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies Límite: Adolescent / Adult / Female / Humans País/Región como asunto: Europa Idioma: En Revista: Fam Cancer Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Países Bajos